Basit öğe kaydını göster

dc.contributor.authorSen, Nazan
dc.contributor.authorAydin Tufan, Muge
dc.contributor.authorYildiz, Reyhan
dc.contributor.authorErsozlu Bozkirli, Emine Duygu
dc.contributor.authorYucel, Eftal
dc.date.accessioned2019-06-20T10:31:31Z
dc.date.available2019-06-20T10:31:31Z
dc.date.issued2016
dc.identifier.issn0494-1373
dc.identifier.urihttp://tuberktoraks.org/managete/fu_folder/2016-03/2016-64-03-223-229.pdf
dc.identifier.urihttp://hdl.handle.net/11727/3630
dc.description.abstractIntroduction: To evaluate long-term outcome of patients with granulomatous polyangitis (GPA) followed up in a tertiary university hospital. Patients and Methods: We reviewed medical records of 22 patients with GPA diagnosis confirmed by tissue biopsies between 2004 and 2014. Results: The mean time from the onset of symptoms to diagnosis was 7.8 +/- 12.3 months [interquartile range (IR)= 4.0]. The most commonly involved organs were the upper respiratory tract (URT) (72.7%), lower respiratory tract (81.8%) and kidneys (72.7%). URT involvement indicated good prognosis (p= 0.046). Survival in the patients with and without URT involvement was 124.6 +/- 6.9 months and 59.7 +/- 22.9 months, respectively. End-stage renal failure (ESRF) requiring dilaysis and cardiac involvement were associated with mortality (p= 0.022 and p= 0.026, respectively). Of the 12 dialysis-dependent patients at diagnosis, 11 survived > 3 months and seven regained renal function permanently. Dialysis dependency was significantly lower in patients who received plasmapheresis (p= 0.047). Overall mortality rate was 18% (4/22). Mean survival was 55.9 +/- 42.8 months (IR= 84.0). Conclusion: Diagnosis of GPA may be delayed by the nonspecific nature of its symptoms. URT involvement was associated with good prognosis, whereas cardiac involvement and ESRF requiring dialysis were associated with poor outcome. Plasmapheresis may increase the rate of renal recovery in the patients with ESRF requiring dialysis.en_US
dc.language.isoengen_US
dc.relation.isversionof10.5578/tt.25269en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGranulomatosis polyangitisen_US
dc.subjectOutcomeen_US
dc.subjectVasculitisen_US
dc.subjectWegener granulomatosisen_US
dc.titleGranulomatous polyangitis (Wegener granulomatosis): Clinical findings and results of long-term follow-upen_US
dc.typearticleen_US
dc.relation.journalTUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAXen_US
dc.identifier.volume64en_US
dc.identifier.issue3en_US
dc.identifier.startpage223en_US
dc.identifier.endpage229en_US
dc.identifier.wos000389842500007en_US
dc.identifier.scopus2-s2.0-85007028238en_US
dc.contributor.pubmedID28393729en_US
dc.contributor.orcID0000-0002-4171-7484en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.contributor.researcherIDAAI-8947-2021en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster